Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Debt / NOTE 3.000%12/0
-
Market price (% of par)
-
105.06%
-
Total 13F principal
-
$127,882,000
-
Principal change
-
+$115,542,000
-
Total reported market value
-
$134,255,000
-
Number of holders
-
19
-
Value change
-
+$121,311,000
-
Number of buys
-
17
Institutional Holders of ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 as of Q4 2014
As of 31 Dec 2014,
ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 was held by
19 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$127,882,000
in principal (par value) of the bond.
The largest 10 bondholders included
Citadel Advisors LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Hudson Bay Capital Management LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, WOLVERINE ASSET MANAGEMENT LLC, GUARDIAN LIFE INSURANCE CO OF AMERICA, PERCEPTIVE ADVISORS LLC, ADVENT CAPITAL MANAGEMENT /DE/, UBS OCONNOR LLC, and Context Capital Management, LLC.
This page lists
19
institutional bondholders reporting positions
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.